Induction of B-cell lymphoma by UVB Radiation in p53 Haploinsufficient Mice

被引:9
|
作者
Puebla-Osorio, Nahum [1 ,2 ]
Miyahara, Yasuko [4 ]
Coimbatore, Sreevidya [1 ,2 ]
Limon-Flores, Alberto Y. [5 ]
Kazimi, Nasser [1 ,2 ]
Ullrich, Stephen E. [1 ,2 ,3 ]
Zhu, Chengming [1 ,2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA
[3] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA
[4] Kyoto City Hosp, Dept Hematol, Nakagyo Ku, Kyoto 6048845, Japan
[5] IPN, Escuela Nacl Ciencias Biol, Mexico City 07738, DF, Mexico
来源
BMC CANCER | 2011年 / 11卷
关键词
NON-HODGKINS-LYMPHOMA; PLATELET-ACTIVATING-FACTOR; CLASS-SWITCH RECOMBINATION; ULTRAVIOLET-RADIATION; IMMUNE SUPPRESSION; SKIN-CANCER; VITAMIN-D; IN-VIVO; EXPRESSION; EXPOSURE;
D O I
10.1186/1471-2407-11-36
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The incidence of non-Hodgkin's lymphoma has increased over recent years. The exact etiology of lymphoma remains unknown. Ultraviolet light exposure has been associated with the development of internal lymphoid malignancies and some reports suggest that it may play a role in the development of lymphoma in humans. Here we describe the characterization and progression of lymphoma in p53 heterozygous mice exposed to UVB irradiation. Methods: UVB-irradiated p53(+/-) mice developed enlargement of the spleen. Isolated spleen cells were transplanted into Rag deficient hosts. The UV-induced tumor cells were analyzed by flow cytometry. The tumor cells were tagged with GFP to study their metastatic potential. SKY and karyotypic analysis were carried out for the detection of chromosomal abnormalities. Functional assays included in vitro class switch recombination assay, immunoglobulin rearrangement assay, as well as cytokine profiling. Results: UVB-exposed mice showed enlargement of the spleen and lymph nodes. Cells transplanted into Rag deficient mice developed aggressive tumors that infiltrated the lymph nodes, the spleen and the bone marrow. The tumor cells did not grow in immune competent syngeneic C57Bl/6 mice yet showed a modest growth in UV-irradiated B6 mice. Phenotypic analysis of these tumor cells revealed these cells are positive for B cell markers CD19(+), CD5(+), B220(+), IgM(+) and negative for T cell, NK or dendritic cell markers. The UV-induced tumor cells underwent robust in vitro immunoglobulin class switch recombination in response to lipopolysaccharide. Cytogenetic analysis revealed a t(14;19) translocation and trisomy of chromosome 6. These tumor cells secret IL-10, which can promote tumor growth and cause systemic immunosuppression. Conclusion: UV-irradiated p53(+/-) mice developed lymphoid tumors that corresponded to a mature B cell lymphoma. Our results suggest that an indirect mechanism is involved in the development of internal tumors after chronic exposure to UV light. The induction of B cell lymphoma in UV-irradiated p53 heterozygous mice may provide a useful model for lymphoma development in humans.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
    Li, Xinyi
    Luo, Danju
    Zhang, Liling
    Li, Qiuhui
    Fan, Jun
    Zhang, Jiwei
    Huang, Bo
    Yang, Ming
    Nie, Xiu
    Chang, Xiaona
    Pan, Huaxiong
    BMC CANCER, 2023, 23 (01)
  • [32] Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma
    Sohn, SK
    Jung, JT
    Kim, DH
    Kim, JG
    Kwak, EK
    Park, TI
    Shin, DG
    Sohn, KR
    Lee, KB
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (02) : 101 - 107
  • [33] Diclofenac Induces Apoptosis and Suppresses Diffuse Large B-Cell Lymphoma Proliferation Independent of P53 Status
    Hassan, Hesham
    Varney, Michelle
    Dave, Bhavana J.
    Singh, Rakesh K.
    BLOOD, 2014, 124 (21)
  • [34] PRESENCE OF CIRCULATING ANTIBODIES AGAINST CELLULAR PROTEIN P53 IN A NOTABLE PROPORTION OF CHILDREN WITH B-CELL LYMPHOMA
    DEFROMENTEL, CC
    MAYLEVIN, F
    MOURIESSE, H
    LEMERLE, J
    CHANDRASEKARAN, K
    MAY, P
    INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) : 185 - 189
  • [35] B-Cell Progenitors Are Reduced in Hspa9 haploinsufficient Mice
    Krysiak, Kilannin
    Chen, Tim H.
    Tibbitts, Justin
    Martin, Michael G.
    Walter, Matthew J.
    BLOOD, 2011, 118 (21) : 1636 - 1636
  • [36] Prognostic Significance of p53 and p63 in Diffuse Large B-Cell Lymphoma: A Single-Institution Experience
    Moreno, Juan Carlos Alvarez
    Bahmad, Hisham F.
    Aljamal, Abed Alhalim
    Delgado, Ruben
    Salami, Ali
    Guillot, Carolina
    Castellano-Sanchez, Amilcar A.
    Medina, Ana Maria
    Sriganeshan, Vathany
    CURRENT ONCOLOGY, 2023, 30 (02) : 1314 - 1331
  • [37] P53 MUTATIONS IN MANTLE CELL LYMPHOMA
    GREINER, TC
    MOYNIHAN, MJ
    CHAN, WC
    LYTLE, DM
    WEISENBURGER, DD
    LABORATORY INVESTIGATION, 1995, 72 (01) : A111 - A111
  • [38] 2-HYDROXYETHYLNITROSOUREA INDUCTION OF B-CELL LYMPHOMA IN FEMALE SWISS MICE
    MIRVISH, SS
    WEISENBURGER, DD
    JOSHI, SS
    NICKOLS, J
    CANCER LETTERS, 1990, 54 (1-2) : 101 - 106
  • [39] Clinical significance of detecting p53 protein in Burkitt lymphoma and B-cell acute lymphoblastic leukemia using immunocytochemistry
    Nagai, J
    Kigasawa, H
    Koga, N
    Katoh, A
    Nishihira, H
    Nagao, T
    LEUKEMIA & LYMPHOMA, 1998, 28 (5-6) : 591 - +
  • [40] Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma
    Stefancikova, Lenka
    Moulis, Mojmir
    Fabian, Pavel
    Vasova, Ingrid
    Zedek, Frantisek
    Ravcukova, Barbora
    Muzik, Jan
    Kuglik, Petr
    Vranova, Vladimira
    Falkova, Iva
    Hrabalkova, Renata
    Smardova, Jana
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (06) : 1413 - 1420